Table 2 Univariate association between treatment factors and MACE.
Patients | MACE | OR (95% CI) | p Value | |
---|---|---|---|---|
Restenotic lesions | ||||
No | 93.0% | 1.3% | Reference | |
Yes | 7.0% | 1.0% | 0.76 (0.35 to 1.63) | 0.47 |
AHA type C lesions | ||||
No | 57.4% | 1.0% | Reference | |
Yes | 42.6% | 1.7% | 1.72 (1.21 to 2.44) | 0.002 |
LMS lesions | ||||
No | 98.9% | 1.2% | Reference | |
Yes | 1.1% | 9.5% | 8.57 (4.36 to 16.85) | <0.001 |
Graft lesions | ||||
No | 96.3% | 1.3% | Reference | |
Yes | 3.7% | 2.7% | 2.24 (1.16 to 4.31) | 0.013 |
Thrombus present | ||||
No | 87.9% | 1.0% | Reference | |
Yes | 12.1% | 3.3% | 3.23 (2.21 to 4.72) | <0.001 |
Multivessel PCI | ||||
No | 77.2% | 1.2% | Reference | |
Yes | 22.8% | 1.5% | 1.22 (0.82 to 1.80) | 0.33 |
Chronic occlusion | ||||
No | 88.7% | 1.2% | Reference | |
Yes | 11.3% | 2.1% | 1.81 (1.16 to 2.83) | 0.008 |
AHA, American Heart Association.